Literature DB >> 3125942

Sulfadoxine-pyrimethamine resistant malaria from west or central Africa.

J Gubler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125942      PMCID: PMC2545020          DOI: 10.1136/bmj.296.6619.433-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.

Authors:  A Schapira; I C Bygbjerg; S Jepsen; H Flachs; M W Bentzon
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

2.  Possible role of drug malabsorption in recrudescence of falciparum malaria.

Authors:  C Herzog; C J Ellis; J A Innes; K A Fletcher
Journal:  Lancet       Date:  1982-11-20       Impact factor: 79.321

3.  Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; B Meemanee; W Wernsdorfer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.

Authors:  E Weidekamm; H Plozza-Nottebrock; I Forgo; U C Dubach
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

  4 in total
  3 in total

1.  The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.

Authors:  P A Winstanley; W M Watkins; C R Newton; C Nevill; E Mberu; P A Warn; C M Waruiru; I N Mwangi; D A Warrell; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

Review 2.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.

Authors:  P A Winstanley; E K Mberu; I S Szwandt; A M Breckenridge; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.